XML 58 R43.htm IDEA: XBRL DOCUMENT v3.23.2
Revenue - Business Revenue (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Jul. 01, 2023
Jun. 25, 2022
Jul. 01, 2023
Jun. 25, 2022
Disaggregation of Revenue [Line Items]        
Revenues $ 984.4 $ 1,002.7 $ 3,085.1 $ 3,909.6
United States        
Disaggregation of Revenue [Line Items]        
Revenues 750.1 734.6 2,342.5 2,739.4
International        
Disaggregation of Revenue [Line Items]        
Revenues 234.3 268.1 742.6 1,170.2
Diagnostics        
Disaggregation of Revenue [Line Items]        
Revenues 439.7 560.1 1,463.6 2,497.6
Diagnostics | United States        
Disaggregation of Revenue [Line Items]        
Revenues 330.6 387.4 1,086.9 1,647.8
Diagnostics | International        
Disaggregation of Revenue [Line Items]        
Revenues 109.1 172.7 376.7 849.8
Diagnostics | Cytology & Perinatal        
Disaggregation of Revenue [Line Items]        
Revenues 126.8 115.9 365.4 362.0
Diagnostics | Cytology & Perinatal | United States        
Disaggregation of Revenue [Line Items]        
Revenues 79.7 74.3 226.9 227.4
Diagnostics | Cytology & Perinatal | International        
Disaggregation of Revenue [Line Items]        
Revenues 47.1 41.6 138.5 134.6
Diagnostics | Molecular Diagnostics        
Disaggregation of Revenue [Line Items]        
Revenues 302.2 435.3 1,069.7 2,111.1
Diagnostics | Molecular Diagnostics | United States        
Disaggregation of Revenue [Line Items]        
Revenues 240.2 304.2 831.5 1,395.9
Diagnostics | Molecular Diagnostics | International        
Disaggregation of Revenue [Line Items]        
Revenues 62.0 131.1 238.2 715.2
Diagnostics | Blood Screening        
Disaggregation of Revenue [Line Items]        
Revenues 10.7 8.9 28.5 24.5
Diagnostics | Blood Screening | United States        
Disaggregation of Revenue [Line Items]        
Revenues 10.7 8.9 28.5 24.5
Diagnostics | Blood Screening | International        
Disaggregation of Revenue [Line Items]        
Revenues 0.0 0.0 0.0 0.0
Breast Health        
Disaggregation of Revenue [Line Items]        
Revenues 360.3 282.8 1,079.9 952.7
Breast Health | United States        
Disaggregation of Revenue [Line Items]        
Revenues 279.9 222.3 843.2 732.9
Breast Health | International        
Disaggregation of Revenue [Line Items]        
Revenues 80.4 60.5 236.7 219.8
Breast Health | Breast Imaging        
Disaggregation of Revenue [Line Items]        
Revenues 286.1 212.2 862.1 739.5
Breast Health | Breast Imaging | United States        
Disaggregation of Revenue [Line Items]        
Revenues 220.7 165.5 666.5 561.8
Breast Health | Breast Imaging | International        
Disaggregation of Revenue [Line Items]        
Revenues 65.4 46.7 195.6 177.7
Breast Health | Interventional Breast Solutions        
Disaggregation of Revenue [Line Items]        
Revenues 74.2 70.6 217.8 213.2
Breast Health | Interventional Breast Solutions | United States        
Disaggregation of Revenue [Line Items]        
Revenues 59.2 56.8 176.7 171.1
Breast Health | Interventional Breast Solutions | International        
Disaggregation of Revenue [Line Items]        
Revenues 15.0 13.8 41.1 42.1
GYN Surgical        
Disaggregation of Revenue [Line Items]        
Revenues 157.3 138.1 456.2 389.6
GYN Surgical | United States        
Disaggregation of Revenue [Line Items]        
Revenues 122.9 112.2 359.6 315.4
GYN Surgical | International        
Disaggregation of Revenue [Line Items]        
Revenues 34.4 25.9 96.6 74.2
Skeletal Health        
Disaggregation of Revenue [Line Items]        
Revenues 27.1 21.7 85.4 69.7
Skeletal Health | United States        
Disaggregation of Revenue [Line Items]        
Revenues 16.7 12.7 52.8 43.3
Skeletal Health | International        
Disaggregation of Revenue [Line Items]        
Revenues $ 10.4 $ 9.0 $ 32.6 $ 26.4